Publication | Open Access
CRISPR activation and interference screens decode stimulation responses in primary human T cells
291
Citations
47
References
2022
Year
T-regulatory CellImmunologyImmune RegulationImmunologic MechanismGenome-wide Crispr ActivationCd4 T Cell ResponsesImmunotherapeuticsImmune Cell TherapyImmunotherapyCrispr ActivationStimulated T CellsCrisprOff-target EffectCell SignalingArrayed CrispraAutoimmunityT Cell ImmunityGenome EditingImmune FunctionCell BiologyCytokineSignal TransductionImmune Cell DevelopmentGene EditingCellular Immune ResponseMedicineCell Development
Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1